Identifying significant contributors for smoking cessation among male prisoners in Australia: results from a randomised clinical trial.

illicit drug use mental health physical health population attributable risk prisoners smoking cessation

Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
20 07 2020
Historique:
entrez: 22 7 2020
pubmed: 22 7 2020
medline: 16 2 2021
Statut: epublish

Résumé

In Australia, an estimated 90% of those entering prison are current tobacco smokers and three-quarters of current prisoners are tobacco smokers. To identify factors and their relative contributions to smoking cessation among male prisoners. A total of 425 male tobacco smokers with a median age of 32 years in Australian prisons. The primary outcome was continuous abstinence at 3, 6 and 12 months. We measured various sociodemographic characteristics, drug use, psychological distress and the mental and physical health status of the participants. Multivariate logistic regression models and population attributable risks (PAR%) were used to identify the significant factors and their contributions to smoking cessation rates. The median age of participants was 32 years (IQR 25-41 years). High smoking cessation rates were collectively associated with not using drugs, lower psychological distress, good mental health scores and better physical health (PAR%: 93%, 98% and 88% at 3, 6 and 12 months). Our study suggests that not using drugs and being in good mental/physical health are the important contributors to continuous abstinence among prisoners. Thus, effective smoking cessation programmes require a multicomponent approach that includes addressing drug problems and mental health functioning. 12606000229572.

Identifiants

pubmed: 32690730
pii: bmjopen-2019-034046
doi: 10.1136/bmjopen-2019-034046
pmc: PMC7375500
doi:

Types de publication

Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e034046

Informations de copyright

© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

Addiction. 1993 Jun;88(6):791-804
pubmed: 8329970
Aust N Z J Psychiatry. 2012 Sep;46(9):851-63
pubmed: 22645396
Drug Alcohol Depend. 2018 Jun 1;187:127-133
pubmed: 29660697
Arch Gen Psychiatry. 1991 Dec;48(12):1069-74
pubmed: 1845224
J Correct Health Care. 2009 Jul;15(3):190-6
pubmed: 19477804
Addict Behav. 2005 Mar;30(3):589-94
pubmed: 15718077
Tob Control. 2014 Jan;23(1):33-8
pubmed: 23111538
JAMA Intern Med. 2013 May 13;173(9):789-94
pubmed: 23567902
Addict Behav. 1994 Sep-Oct;19(5):497-507
pubmed: 7832008
Psychol Med. 2004 Feb;34(2):323-33
pubmed: 14982138
Drug Alcohol Rev. 2014 Sep;33(5):534-9
pubmed: 25069871
BMC Public Health. 2011 Jul 28;11:598
pubmed: 21798059
Addiction. 2013 May;108(5):966-74
pubmed: 23228222
CMAJ. 2013 Jul 9;185(10):E474
pubmed: 23670153
Nicotine Tob Res. 2011 Jun;13(6):449-56
pubmed: 21447838
BMJ. 2014 Aug 05;349:g4542
pubmed: 25097186
Am J Public Health. 2015 Feb;105(2):e3
pubmed: 25521889
Br J Addict. 1991 Sep;86(9):1119-27
pubmed: 1932883
Drug Alcohol Depend. 2004 Dec 7;76(3):287-95
pubmed: 15561479
Int J Public Health. 2009 Jun;54 Suppl 1:68-74
pubmed: 19396580
Drug Alcohol Rev. 2006 Jan;25(1):85-96
pubmed: 16492581
Nicotine Tob Res. 2014 Jun;16(6):800-6
pubmed: 24480803
Aust N Z J Public Health. 1999 Jun;23(3):245-8
pubmed: 10388166
AIDS Care. 2012;24(9):1155-62
pubmed: 22709144
JAMA. 1990 Sep 26;264(12):1546-9
pubmed: 2395194
Respir Care. 2016 Apr;61(4):434-8
pubmed: 26670470
Am Fam Physician. 2000 Mar 1;61(5):1409-16
pubmed: 10735346
Psychol Med. 2002 Aug;32(6):959-76
pubmed: 12214795

Auteurs

Handan Wand (H)

Kirby Institute, University of New South Wales, Sydney, New South Wales, Australia.

Robyn Richmond (R)

School of Public Health and Community Medicine, University of New South Wales, Sydney, New South Wales, Australia.

Armita Adily (A)

Kirby Institute, University of New South Wales, Sydney, New South Wales, Australia.

Andrea Le (A)

Kirby Institute, University of New South Wales, Sydney, New South Wales, Australia.

Kay Wilhelm (K)

School of Psychiatry, University of New South Wales, Sydney, Australila.

Tony Butler (T)

Kirby Institute, University of New South Wales, Sydney, New South Wales, Australia tbutler@kirby.unsw.edu.au.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH